Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage

Mucosal Immunology

Volumn 9, Issue 1, 2016, Pages 56-67

  Glennie, S ^a,d   Gritzfeld, J F ^a   Pennington, S H ^a   Garner Jones, M ^a   Coombes, N ^a   Hopkins, M J ^b   Vadesilho, C F ^c   Miyaji, E N ^c   Wang, D ^a   Wright, A D ^a,b   Collins, A M ^a,b   Gordon, S B ^a   Ferreira, D M ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c INSTITUTO BUTANTAN   (Brazil)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT FACTOR H; PNEUMOCOCCAL SURFACE PROTEIN C; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; PROTEIN BINDING; SPSA PROTEIN, STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BINDING SITE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; MALE; MIXED INFECTION; NASOPHARYNX; NORMAL HUMAN; NOSE MUCOSA; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; SCREENING; VIRAL UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; AMINO ACID SEQUENCE; BIOSYNTHESIS; CHEMISTRY; CLINICAL TRIAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MUCOSAL IMMUNITY; PATHOGENICITY; PATHOLOGY; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; BINDING SITES; COINFECTION; COMPLEMENT FACTOR H; EPITOPE MAPPING; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PROTEIN BINDING; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VIRUS DISEASES;

EID: 84953335531     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.35     Document Type: Article

References (49)

1. Morens, D.M., Taubenberger, J.K., & Fauci, A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962-970 (2008
2. McCullers J.A., et al. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J. Infect. Dis. 202, 1287-1295 (2010
3. Vu, H.T., et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr. Infect. Dis. J. 30, 11-18 (2011
4. Short K.R., et al. Influenza virus induces bacterial and nonbacterial otitis media. J. Infect. Dis. 204, 1857-1865 (2011
5. Nakamura, S., Davis, K.M., & Weiser, J.N. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121, 3657-3665 (2011
6. Gray, B.M., Converse, G.M. 3rd & Dillon, H.C. Jr Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142, 923-933 (1980
7. Bogaert, D., De, G.R., & Hermans, P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4, 144 (2004
8. Didierlaurent A., et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205, 323-329 (2008
9. Hussell, T., & Goulding, J. Structured regulation of inflammation during respiratory viral infection. Lancet Infect. Dis. 10, 360-366 (2010
10. Pittet, L.A., Hall-Stoodley, L., Rutkowski, M.R., & Harmsen, A.G. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 42, 450-460 (2010
11. Faure, M., & Rabourdin-Combe, C. Innate immunity modulation in virus entry. Curr. Opin. Virol. 1, 6-12 (2011
12. Vareille, M., Kieninger, E., Edwards, M.R., & Regamey, N. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 24, 210-229 (2011
13. Gritzfeld J.F., et al. Experimental human pneumococcal carriage. J. Vis. Exp. 72, 50115 (2013
14. Wright A.K., et al. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog. 9, e1003274 (2013
15. Wright A.K., et al. Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog. 8, e1002622 (2012
16. Ferreira, D.M., Jambo, K.C., & Gordon, S.B. Experimental human pneumococcal carriage models for vaccine research. Trends Microbiol. 19, 464-470 (2011
17. Ferreira D.M., et al. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am. J. Respir. Crit. Care Med. 187, 855-864 (2013
18. Jarva, H., Janulczyk, R., Hellwage, J., Zipfel, P.F., Bjorck, L., & Meri, S. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J. Immunol. 168, 1886-1894 (2002
19. Dave, S., Brooks-Walter, A., Pangburn, M.K., & McDaniel, L.S. PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69, 3435-3437 (2001
20. Hammerschmidt, S., Agarwal, V., Kunert, A., Haelbich, S., Skerka, C., & Zipfel, P.F. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J. Immunol. 178, 5848-5858 (2007
21. Dave, S., Carmicle, S., Hammerschmidt, S., Pangburn, M.K., & McDaniel, L.S. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J. Immunol. 173, 471-477 (2004
22. Balachandran, P., Brooks-Walter, A., Virolainen-Julkunen, A., Hollingshead, S.K., & Briles, D.E. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70, 2526-2534 (2002
23. Agarwal, V., Asmat, T.M., Luo, S., Jensch, I., Zipfel, P.F., & Hammerschmidt, S. Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J. Biol. Chem. 285, 23486-23495 (2010
24. Janoff E.N., et al. Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunol. 7, 249-256 (2013
25. Lu, L., Ma, Z., Jokiranta, T.S., Whitney, A.R., DeLeo, F.R., & Zhang, J.R. Species-specific interaction of Streptococcus pneumoniae with human complement factor H. J. Immunol. 181, 7138-7146 (2008
26. Hammerschmidt, S., Tillig, M.P., Wolff, S., Vaerman, J.P., & Chhatwal, G.S. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol.Microbiol. 36, 726-736 (2000
27. Quin, L.R., Onwubiko, C., Carmicle, S., & McDaniel, L.S. Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H. FEMS Microbiol. Lett. 264, 98-103 (2006
28. Wolter, N., et al. High nasopharyngeal pneumococcal density, increased by viral co-infection, is associated with invasive pneumococcal pneumonia. J. Infect. Dis. 210, 1649-1657 (2014
29. Kimaro Mlacha S.Z., et al. Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection. BMC Genomics 14, 378 (2013
30. Kadioglu, A., Weiser, J.N., Paton, J.C., & Andrew, P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6, 288-301 (2008
31. Voss S., et al. The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-Terminal heparin-binding domain of vitronectin. J. Biol. Chem. 288, 15614-15627 (2013
32. Ferreira D.M., et al. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin. Vaccine Immunol. 16, 636-645 (2009
33. Hernani Mde, L., Ferreira, P.C., Ferreira, D.M., Miyaji, E.N., Ho, P.L., & Oliveira, M.L. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice. FEMS Immunol. Med. Microbiol. 62, 263-272 (2011
34. Brooks-Walter, A., Briles, D.E., & Hollingshead, S.K. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 67, 6533-6542 (1999
35. Melin, M., Coan, P., & Hollingshead, S. Development of cross-reactive antibodies to the proline-rich region of pneumococcal surface protein A in children. Vaccine 30, 7157-7160 (2012
36. Yuste J., et al. The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect. Immun. 78, 283-292 (2010
37. Agarwal, V., Asmat, T.M., Luo, S., Jensch, I., Zipfel, P.F., & Hammerschmidt, S. Complement regulator FactorHmediates a two-step uptake ofStreptococcus pneumoniae by human cells. J. Biol. Chem. 285, 23486-23495 (2010
38. Quin, L.R., Onwubiko, C., Moore, Q.C., Mills, M.F., McDaniel, L.S., & Carmicle, S. Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo. Infect. Immun. 75, 4082-4087 (2007
39. Fleming-Dutra K.E., et al. Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. J. Infect. Dis. 207, 1135-1143 (2013
40. Emonts, M., et al. Host polymorphismsin interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J. Infect. Dis. 197, 1244-1253 (2008
41. Madico G., et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J. Immunol. 177, 501-510 (2006
42. Snape M.D., et al. Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Pediatr. Infect. Dis. J. 29, e71-e79 (2010
43. Santolaya, M.E., et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 379, 617-624 (2012
44. Pollard, A.J., Riordan, A., & Ramsay, M. Group B meningococcal vaccine: recommendations for UK use. Lancet 383, 1103-1104 (2014
45. Beernink P.T., et al. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J. Immunol. 186, 3606-3614 (2011
46. Bezerra P.G., et al. Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One 6, e18928 (2011
47. Hopkins, M.J., Moorcroft, J.F., Correia, J.B., & Hart, I.J. Using the full spectral capacity (six channels) of a real-Time PCR instrument can simplify diagnostic laboratory screening and typing protocols for pandemic H1N1 influenza. Influenza Other Resp. Viruses 5, 110-114 (2011
48. Hyams, C., Tam, J.C., Brown, J.S., & Gordon, S.B. C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection. PLoS One 5, e8902 (2010
49. Vadesilho C.F., et al. Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC. Clin. Vaccine Immunol. 21, 940-948 (2014